Feb 22 2010
SNPwatch: Enzyme Deficiency May Protect Against Serious Hepatitis C Treatment Side Effect
People chronically infected with the hepatitis C virus currently have only one treatment option: a combination of polyethylene glycol (PEG)-ylated interferon alpha and ribavirin (RBV). Not only does this drug regimen fail to eradicate the virus in about half of all patients who receive it, but even when it does work the side effects can [...]
